Allarity Therapeutics Inc (NASDAQ:ALLR) price on Thursday, March 20, fall -4.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.96.
A look at the stock’s price movement, the close in the last trading session was $1.00, moving within a range at $0.92 and $1.01. The beta value (5-Year monthly) was 0.25. Turning to its 52-week performance, $214.58 and $0.68 were the 52-week high and 52-week low respectively. Overall, ALLR moved 2.71% over the past month.
Allarity Therapeutics Inc’s market cap currently stands at around $4.26 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ALLR is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ALLR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ALLR’s current price about 2.99% and -7.03% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.94, while 7-day volatility ratio is 16.61% and 15.43% in the 30-day chart. Further, Allarity Therapeutics Inc (ALLR) has a beta value of -0.07, and an average true range (ATR) of 0.14.
If we refocus on Allarity Therapeutics Inc (NASDAQ:ALLR), historical trading data shows that trading volumes averaged 2.34 over the past 10 days and 2.66 million over the past 3 months. The company’s latest data on shares outstanding shows there are 4.43 million shares.
The 23.57% of Allarity Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 2.36% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.66 million on 2025-02-28, giving us a short ratio of 0.44. The data shows that as of 2025-02-28 short interest in Allarity Therapeutics Inc (ALLR) stood at 1481.0 of shares outstanding, with shares short rising to 0.49 million registered in 2025-01-31. Current price change has pushed the stock -17.95% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ALLR stock continues to rise going into the next quarter.
